These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28292339)

  • 1. Comparison of Ferric Sulfate Combined Mineral Trioxide Aggregate Pulpotomy and Zinc Oxide Eugenol Pulpectomy of Primary Maxillary Incisors: An 18-month Randomized, Controlled Trial.
    Nguyen TD; Judd PL; Barrett EJ; Sidhu N; Casas MJ
    Pediatr Dent; 2017 Jan; 39(1):34-38. PubMed ID: 28292339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
    Doyle TL; Casas MJ; Kenny DJ; Judd PL
    Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis.
    Asgary S; Shirvani A; Fazlyab M
    J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and radiographic success rates of mineral trioxide aggregate and ferric sulphate pulpotomies performed by dental students.
    Odabaş ME; Alaçam A; Sillelioğlu H; Deveci C
    Eur J Paediatr Dent; 2012 Jun; 13(2):118-22. PubMed ID: 22762173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of vital primary incisor ferric sulfate pulpotomy and root canal therapy.
    Casas MJ; Kenny DJ; Johnston DH; Judd PL; Layug MA
    J Can Dent Assoc; 2004 Jan; 70(1):34-8. PubMed ID: 14709254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulpotomy versus pulpectomy in carious vital pulp exposure in primary incisors: a randomized controlled trial.
    Gadallah LK; Elbardissy A; Elyazeed MA; Alsamad AA; Hamdy M
    BMC Oral Health; 2024 Mar; 24(1):354. PubMed ID: 38504243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
    Carti O; Oznurhan F
    Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
    Patidar S; Kalra N; Khatri A; Tyagi R
    J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up.
    Ansari G; Ranjpour M
    Int Endod J; 2010 May; 43(5):413-8. PubMed ID: 20518934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.